Table of Content

1. Executive Summary
1.1. Global Xerostomia (Dry Mouth) Treatment Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025 – 2032, US$ Bn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors – Relevance and Impact
3. Value Added Insights
3.1. Product Adoption Analysis
3.2. Regulatory Landscape
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter’s Five Force Analysis
4. Pricing Analysis, 2025
4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Pricing Analysis, By Product Type
4.4. Regional Prices and Product Preferences
5. Global Xerostomia (Dry Mouth) Treatment Market Outlook:
5.1. Key Highlights
5.1.1. Market Volume (Units) Projections
5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Bn) Analysis and Forecast
5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025–2032
5.3. Global Xerostomia (Dry Mouth) Treatment Market Outlook: Product Type
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product Type, 2019-2023
5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025–2032
5.3.3.1. Saliva Substitutes
5.3.3.2. Saliva Stimulants
5.3.3.3. Over-the-counter (OTC) Drugs
5.3.3.4. Others
5.4. Market Attractiveness Analysis: Product Type
5.5. Global Xerostomia (Dry Mouth) Treatment Market Outlook: Formulation
5.5.1. Introduction / Key Findings
5.5.2. Historical Market Size (US$ Bn) Analysis, By Formulation, 2019-2023
5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Formulation, 2025–2032
5.5.3.1. Oral Sprays
5.5.3.2. Oral Solutions
5.5.3.3. Gels
5.5.3.4. Powders
5.5.3.5. Others
5.6. Market Attractiveness Analysis: Formulation
5.7. Global Xerostomia (Dry Mouth) Treatment Market Outlook: Age Group
5.7.1. Introduction / Key Findings
5.7.2. Historical Market Size (US$ Bn) Analysis, By Age Group, 2019-2023
5.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2025–2032
5.7.3.1. Geriatric
5.7.3.2. Adult
5.7.3.3. Pediatrics
5.8. Market Attractiveness Analysis: Age Group
5.9. Global Xerostomia (Dry Mouth) Treatment Market Outlook: Distribution Channel
5.9.1. Introduction / Key Findings
5.9.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2023
5.9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025–2032
5.9.3.1. Hospital Pharmacies
5.9.3.2. Retail Pharmacies
5.9.3.3. Drug Stores
5.9.3.4. Others
5.10. Market Attractiveness Analysis: Distribution Channel
6. Global Xerostomia (Dry Mouth) Treatment Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2023
6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025–2032
6.3.1. North America
6.3.2. Europe
6.3.3. East Asia
6.3.4. South Asia and Oceania
6.3.5. Latin America
6.3.6. Middle East and Africa
6.4. Market Attractiveness Analysis: Region
7. North America Xerostomia (Dry Mouth) Treatment Market Outlook:
7.1. Key Highlights
7.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
7.2.1. By Country
7.2.2. By Product Type
7.2.3. By Formulation
7.2.4. By Age Group
7.2.5. By Distribution Channel
7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025–2032
7.3.1. U.S.
7.3.2. Canada
7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025–2032
7.4.1. Saliva Substitutes
7.4.2. Saliva Stimulants
7.4.3. Over-the-Counter (OTC) Drugs
7.4.4. Others
7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Formulation, 2025–2032
7.5.1. Oral Sprays
7.5.2. Oral Solutions
7.5.3. Gels
7.5.4. Powders
7.5.5. Others
7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2025–2032
7.6.1. Geriatric
7.6.2. Adult
7.6.3. Pediatrics
7.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025–2032
7.7.1. Hospital Pharmacies
7.7.2. Retail Pharmacies
7.7.3. Drug Stores
7.7.4. Others
7.8. Market Attractiveness Analysis
8. Europe Xerostomia (Dry Mouth) Treatment Market Outlook:
8.1. Key Highlights
8.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
8.2.1. By Country
8.2.2. By Product Type
8.2.3. By Formulation
8.2.4. By Age Group
8.2.5. By Distribution Channel
8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025–2032
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Russia
8.3.7. Türkiye
8.3.8. Rest of Europe
8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025–2032
8.4.1. Ear
8.4.2. Forehead
8.4.3. Multifunction
8.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025–2032
8.5.1. Saliva Substitutes
8.5.2. Saliva Stimulants
8.5.3. Over-the-Counter (OTC) Drugs
8.5.4. Others
8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Formulation, 2025–2032
8.6.1. Oral Sprays
8.6.2. Oral Solutions
8.6.3. Gels
8.6.4. Powders
8.6.5. Others
8.7. Current Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2025–2032
8.7.1. Geriatric
8.7.2. Adult
8.7.3. Pediatrics
8.8. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025–2032
8.8.1. Hospital Pharmacies
8.8.2. Retail Pharmacies
8.8.3. Drug Stores
8.8.4. Others
8.9. Market Attractiveness Analysis
9. East Asia Xerostomia (Dry Mouth) Treatment Market Outlook:
9.1. Key Highlights
9.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
9.2.1. By Country
9.2.2. By Product Type
9.2.3. By Formulation
9.2.4. By Age Group
9.2.5. By Distribution Channel
9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025–2032
9.3.1. China
9.3.2. Japan
9.3.3. South Korea
9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025–2032
9.4.1. Saliva Substitutes
9.4.2. Saliva Stimulants
9.4.3. Over-the-Counter (OTC) Drugs
9.4.4. Others
9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Formulation, 2025–2032
9.5.1. Oral Sprays
9.5.2. Oral Solutions
9.5.3. Gels
9.5.4. Powders
9.5.5. Others
9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2025–2032
9.6.1. Geriatric
9.6.2. Adult
9.6.3. Pediatrics
9.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025–2032
9.7.1. Hospital Pharmacies
9.7.2. Retail Pharmacies
9.7.3. Drug Stores
9.7.4. Others
9.8. Market Attractiveness Analysis
10. South Asia & Oceania Xerostomia (Dry Mouth) Treatment Market Outlook:
10.1. Key Highlights
10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
10.2.1. By Country
10.2.2. By Product Type
10.2.3. By Formulation
10.2.4. By Age Group
10.2.5. By Distribution Channel
10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025–2032
10.3.1. India
10.3.2. Southeast Asia
10.3.3. ANZ
10.3.4. Rest of South Asia & Oceania
10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025–2032
10.4.1. Saliva Substitutes
10.4.2. Saliva Stimulants
10.4.3. Over-the-Counter (OTC) Drugs
10.4.4. Others
10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Formulation, 2025–2032
10.5.1. Oral Sprays
10.5.2. Oral Solutions
10.5.3. Gels
10.5.4. Powders
10.5.5. Others
10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2025–2032
10.6.1. Geriatric
10.6.2. Adult
10.6.3. Pediatrics
10.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025–2032
10.7.1. Hospital Pharmacies
10.7.2. Retail Pharmacies
10.7.3. Drug Stores
10.7.4. Others
10.8. Market Attractiveness Analysis
11. Latin America Xerostomia (Dry Mouth) Treatment Market Outlook:
11.1. Key Highlights
11.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
11.2.1. By Country
11.2.2. By Product Type
11.2.3. By Formulation
11.2.4. By Age Group
11.2.5. By Distribution Channel
11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025–2032
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025–2032
11.4.1. Saliva Substitutes
11.4.2. Saliva Stimulants
11.4.3. Over-the-Counter (OTC) Drugs
11.4.4. Others
11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Formulation, 2025–2032
11.5.1. Oral Sprays
11.5.2. Oral Solutions
11.5.3. Gels
11.5.4. Powders
11.5.5. Others
11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2025–2032
11.6.1. Geriatric
11.6.2. Adult
11.6.3. Pediatrics
11.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025–2032
11.7.1. Hospital Pharmacies
11.7.2. Retail Pharmacies
11.7.3. Drug Stores
11.7.4. Others
11.8. Market Attractiveness Analysis
12. Middle East & Africa Xerostomia (Dry Mouth) Treatment Market Outlook:
12.1. Key Highlights
12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2023
12.2.1. By Country
12.2.2. By Product Type
12.2.3. By Formulation
12.2.4. By Age Group
12.2.5. By Distribution Channel
12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025–2032
12.3.1. GCC Countries
12.3.2. Egypt
12.3.3. South Africa
12.3.4. Northern Africa
12.3.5. Rest of Middle East & Africa
12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2025–2032
12.4.1. Saliva Substitutes
12.4.2. Saliva Stimulants
12.4.3. Over-the-Counter (OTC) Drugs
12.4.4. Others
12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Formulation, 2025–2032
12.5.1. Oral Sprays
12.5.2. Oral Solutions
12.5.3. Gels
12.5.4. Powders
12.5.5. Others
12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Age Group, 2025–2032
12.6.1. Geriatric
12.6.2. Adult
12.6.3. Pediatrics
12.7. Current Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025–2032
12.7.1. Hospital Pharmacies
12.7.2. Retail Pharmacies
12.7.3. Drug Stores
12.7.4. Others
12.8. Market Attractiveness Analysis
13. Competition Landscape
13.1. Market Share Analysis, 2025
13.2. Market Structure
13.2.1. Competition Intensity Mapping By Market
13.2.2. Competition Dashboard
13.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
13.3.1. Daiichi Pharmaceutical Co., Ltd.
13.3.1.1. Overview
13.3.1.2. Segments and Product Types
13.3.1.3. Key Financials
13.3.1.4. Market Developments
13.3.1.5. Market Strategy
13.3.2. Bausch Health Companies Inc. (OraPharma)
13.3.3. Saliwell Ltd.
13.3.4. ADVANZ PHARMA Corp. Limited
13.3.5. CCMed Ltd.
13.3.6. Elevate Oral Care, LLC
13.3.7. Orahealth Corporation
13.3.8. Forward Science
13.3.9. Parnell Pharmaceuticals, Inc.
13.3.10. Cyclacel Pharmaceuticals, Inc.
13.3.11. Midatech Pharma Plc
13.3.12. The 3M Company
13.3.13. Mission Pharmacal
13.3.14. Chattem, Inc. (Sanofi)
13.3.15. Colgate-Palmolive Company
13.3.16. EUSA Pharma, Inc.
13.3.17. Others
14. Appendix
14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations